The PE Ratio as of December 2025 (TTM) for Poniard Pharmaceuticals, Inc. (PARD) is -0.01

According to Poniard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.09% compared to the average of -1.10 of the last 4 quarters.

Poniard Pharmaceuticals, Inc. (PARD) Historical PE Ratio (quarterly & annually)

How has PARD PE Ratio performed in the past?

The mean historical PE Ratio of Poniard Pharmaceuticals, Inc. over the last ten years is -1.30. The current -0.01 PE Ratio has changed -22.96% with respect to the historical average. Over the past ten years (40 quarters), PARD's PE Ratio was at its highest in in the June 2003 quarter at 1.07. The PE Ratio was at its lowest in in the September 2003 quarter at -3.39.

Poniard Pharmaceuticals, Inc. (PARD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Poniard Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Poniard Pharmaceuticals, Inc. (PARD) Average PE Ratio

How has PARD PE Ratio performed in the past?

The current PE Ratio of Poniard Pharmaceuticals, Inc. (PARD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Poniard Pharmaceuticals, Inc. (PARD) PE Ratio vs. Peers

How is PARD’s PE Ratio compared to its peers?

Poniard Pharmaceuticals, Inc.’s PE Ratio is less than VioQuest Pharmaceuticals, Inc. (-0.00), greater than Regenicin, Inc. (-0.02), less than Q BioMed Inc. (-0.00), less than Scopus BioPharma Inc. (-0.00), greater than Strategic Partners A/S (-1504.91), less than RenovaCare, Inc. (-0.00), greater than Vaxxinity, Inc. (-11.11), less than PaxMedica, Inc. Common Stock (-0.00), less than NovAccess Global Inc. (-0.00), less than Aeolus Pharmaceuticals, Inc. (-0.00),

Build a custom stock screener for Poniard Pharmaceuticals, Inc. (PARD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poniard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poniard Pharmaceuticals, Inc. (PARD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poniard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.